Revenue | ₹0.10Cr |
Net Profits | ₹0.49Cr |
Net Profit Margins | 490.00% |
Biogen Pharmachem Industries Ltd’s revenue jumped 84.62% since last year same period to ₹0.10Cr in the Q2 2025-2026. On a quarterly growth basis, Biogen Pharmachem Industries Ltd has generated -106.49% fall in its revenue since last 3-months.
Biogen Pharmachem Industries Ltd’s net profit jumped 51% since last year same period to ₹0.49Cr in the Q2 2025-2026. On a quarterly growth basis, Biogen Pharmachem Industries Ltd has generated -136.57% fall in its net profits since last 3-months.
Biogen Pharmachem Industries Ltd’s net profit margin jumped 218.5% since last year same period to 490.00% in the Q2 2025-2026. On a quarterly growth basis, Biogen Pharmachem Industries Ltd has generated 463.13% jumped in its net profit margins since last 3-months.
The revenue for Biogen Pharmachem Industries Ltd in the Q2 results 2025 was ₹0.10Cr.
The net profit for Biogen Pharmachem Industries Ltd in the Q2 results 2025 was ₹0.49Cr.
The net profit margin for Biogen Pharmachem Industries Ltd in the Q2 results 2025 was 490.00%.
The revenue for Biogen Pharmachem Industries Ltd in the Q2 results 2024 was ₹0.65Cr.
The net profit for Biogen Pharmachem Industries Ltd in the Q2 results 2024 was ₹-1.00Cr.
The net profit margin for Biogen Pharmachem Industries Ltd in the Q2 results 2024 was 153.85%.